These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 12577856)
1. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?]. Petukhov VI; Pavlov BN Ter Arkh; 2002; 74(12):100-4. PubMed ID: 12577856 [No Abstract] [Full Text] [Related]
2. [The therapy of acute myeloid leukemia in patients of advanced age]. Kern W; Schoch C; Fonatsch C; Heinecke A; Wörmann B; Büchner T; Hiddemann W Dtsch Med Wochenschr; 1999 Aug; 124(34-35):1005-14. PubMed ID: 10488328 [No Abstract] [Full Text] [Related]
3. Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia. Buccisano F; Maurillo L; Del Poeta G; Gattei V; Amadori S; Venditti A Haematologica; 2006 Dec; 91(12 Suppl):ELT14; author reply ELT15. PubMed ID: 17194674 [No Abstract] [Full Text] [Related]
4. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia. Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346 [TBL] [Abstract][Full Text] [Related]
6. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial. Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343 [TBL] [Abstract][Full Text] [Related]
7. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M; Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916 [TBL] [Abstract][Full Text] [Related]
8. Granulocytic sarcoma in the absence of myeloid leukemia. Sisack MJ; Dunsmore K; Sidhu-Malik N J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):308-11. PubMed ID: 9270534 [TBL] [Abstract][Full Text] [Related]
9. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia. Lee JH; Choi SJ; Lee JH; Park JH; Kim H; Joo YD; Lee WS; Zang DY; Kim HJ; Lee KH; Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580 [TBL] [Abstract][Full Text] [Related]
10. The outcome of intensive induction therapy in patients >or=70 years with acute myeloid leukemia. Gupta V; Xu W; Keng C; Alibhai SM; Brandwein J; Schimmer A; Schuh A; Yee K; Minden MD Leukemia; 2007 Jun; 21(6):1321-4. PubMed ID: 17344911 [No Abstract] [Full Text] [Related]
11. Whole megakaryocytes are present among CD34+ cells in the peripheral blood of patients with acute myeloid leukemia after intensive chemotherapy. Delfini C; Centis F; Annibali M Haematologica; 1996; 81(3):284-5. PubMed ID: 8767536 [No Abstract] [Full Text] [Related]
16. Elderly acute myeloid leukemia: patients are not all the same. Schaich M Haematologica; 2004 Mar; 89(3):261-3. PubMed ID: 15020259 [No Abstract] [Full Text] [Related]
18. [Diagnostics and therapy of acute myeloid leukemia]. Fritsch S; Metzeler K; Hiddemann W; Buske C Dtsch Med Wochenschr; 2006 Oct; 131(43):2401-6. PubMed ID: 17054056 [No Abstract] [Full Text] [Related]
19. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98. Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120 [TBL] [Abstract][Full Text] [Related]
20. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia. Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]